0001439222-22-000016.txt : 20220223
0001439222-22-000016.hdr.sgml : 20220223
20220223161010
ACCESSION NUMBER: 0001439222-22-000016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220222
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burns James William
CENTRAL INDEX KEY: 0001900772
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 22663643
MAIL ADDRESS:
STREET 1: C/O AGIOS PHARMACEUTICALS
STREET 2: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001439222
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-8600
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20080703
4
1
wf-form4_164565059136535.xml
FORM 4
X0306
4
2022-02-22
0
0001439222
AGIOS PHARMACEUTICALS, INC.
AGIO
0001900772
Burns James William
88 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Legal Officer
Common stock
2022-02-22
4
M
0
724
0
A
15008
D
Common stock
2022-02-22
4
F
0
215
29.08
D
14793
D
Restricted stock units
2022-02-22
4
M
0
724
0
D
Common stock
724.0
0
D
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.
/s/ William Cook, as Attorney in Fact for James Burns
2022-02-23